Director
 |
Jeffrey S. Hoch, PhD, Director Dr Hoch received his PhD in health economics from the Johns Hopkins Bloomberg School of Public Health. Dr. Hoch also holds a Masters in Economics from the Johns Hopkins University and a Bachelor of Arts degree in Quantitative Economics and Decision Sciences from the University of California at San Diego. Dr. Hoch has taught Health Economics and Economic Evaluation classes in Canada and internationally. Currently, he is pursuing research on the statistical methodology and application of health economics. Special interests include health services research related to mental health and other health issues affecting poor and vulnerable populations. Dr. Hoch is the recipient of a Career Scientist Award from the Ontario Ministry of Health and Long Term Care. Click here for more details. |
Administration
 |
Sarah Benn M.A., Network Manager, Canadian Centre for Applied Research in Cancer Control (ARCC). Sarah received her Master’s degree in System, Services and Policy, Department of Health and Aging, McMaster University. She also holds a Bachelor of Arts, Honours Sociology from Bishop’s University. Sarah brings to ARCC strong communication and relationship-building skills, from her experience working with a number of interdisciplinary and inter-professional groups. |
Research
 |
Jaclyn Beca, MSc, Research Coordinator Jaclyn completed her BSc (Honours) in biology and her MSc in health services research at the University of Toronto. |
 |
Dilfuza Djalalova, PhD, Research Assistant Dilfuza received her PhD from the Tashkent State University of Pedagogy in Uzbekistan. She is studying the use of an ICER threshold in health sector decision making. |
 |
Sara Khor, MASc, Health Services Research Associate Sara completed her BASc in Engineering Science and her MASc in Biomaterial and Biomedical Engineering, both at the University of Toronto. She is currently working on the Drug Innovation and personalized medicine projects, which involve looking at the post-market cost, effectiveness and cost-effectiveness of cancer drugs using administrative data in Ontario. She is also studying how ICER thresholds are being used and understood in health sector decision making. |
 |
Jean Yong, MASc, Lead Analyst Jean completed her training in operational research and health economics at University of Toronto. For her masters thesis, she applied operational research technique to help hospital decision makers optimize resource allocation in a surgical setting. Prior to joining this unit, she was an analyst at i3 Innovus, where she worked on health economic and outcomes research projects to inform drug reimbursement decisions. Her research interest focuses on optimizing healthcare resource allocation. In particular, she is interested to understand how evidence can help make better healthcare resource allocation decisions. |
  |
Bing Li, MA, Research Coordinator, Canadian Centre for Applied Research in Cancer Control (ARCC), Bing Li received his Master in Economics from University of Waterloo. He also holds a Bachelor degree in Computer Science from Liaoning University, China. Now, Bing is pursuing a PhD. degree in the Department of Health Policy, Management and Evaluation in University of Toronto. Bing is specifically interested in the methodology of economic evaluation and health econometrics. He had worked as a Health Economic Analyst in a pharmaceutical company for 3 years.
Naushad Budhwani, BC, Research Assistant, Canadian Centre for Applied Research in Cancer Control (ARCC)
|
Capacity Building
 |
Christopher Longo Ph.D, Visiting Fellow, Canadian Centre for Applied Research in Cancer Control, as well as Associate Professor, Health Services Management, DeGroote School of Business, McMaster University. Dr. Longo received his PhD in Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto. Dr. Longo also holds a Masters in Physiology, Faculty of Medicine & Dentistry, University of Western Ontario and a Bachelor of Arts degree in Economics, Faculty of Arts, York University. Christopher Longo has over 20 years industry experience in clinical research, economic evaluation, and market access strategies for the pharmaceutical industry. He has published both clinical and economic research in a number of therapeutic areas including diabetes, cancer, sepsis and central nervous system disorders. His primary research interest is in costs and economic evaluation of cancer programs throughout the cancer journey, intended to inform policy decision making. Additional he has undertaken research on the economics of diabetes and sepsis, behavior characteristics of the demand for health services and global pharmaceutical pricing strategies . Longo has consulted with numerous provincial and federal agencies related to economic evaluation of pharmaceuticals including: the Canadian Agency for Drugs and Technology in Health, Cancer Care Ontario, Ontario Ministry of Health and Long Term Care, and the National Cancer Institute of Canada. |
 |
Sandjar Djalalov, PhD, Post Doctoral Fellow Sandjar is working on economic evaluations of genetic tests and colorectal cancer screening. Dr. Djalalov received his PhD from the Institute of Macroeconomics and Social Studies in Tashkent, Uzbekistan.
|
